Amiloidózis: vizsgálatok itt: Csehország

In Csehország 6 Also abroad 184

6 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.

3. fázisTaking people
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Where
Brno-Stred
Életkor
18 év to 90 év
People
1200 worldwide
Run by
Intellia Therapeutics
See details and how to joinNCT06128629 · EU 2023-507220-23-00
3. fázisCsak meghívásos
A Study to Evaluate Vutrisiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Prague
Életkor
18 év and over
People
700 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT06679946
3. fázisTaking people
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
Where
Brno, Broumov, Olomouc, Ostrava - Poruba, Prague, Uherské Hradiště
Életkor
18 év and over
People
1280 worldwide
Run by
Novo Nordisk A/S
See details and how to joinNCT07207811
3. fázisTaking people
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Where
Brno-Stred, Ostrava, Prague
Életkor
18 év to 85 év
People
1750 worldwide
Run by
Alnylam Pharmaceuticals
See details and how to joinNCT07052903 · EU 2024-519917-72-00
3. fázisNot yet taking people in Csehország
An Open-Label Study to Evaluate the Long-Term Safety and Efficacy of ALXN2220 in Adults With Transthyretin Amyloid Cardiomyopathy
Where
Prague, Praha
People
1180 worldwide
Run by
Alexion Pharmaceuticals, Inc.
See details and how to joinNCT07789483 · EU 2026-526755-57-00
3. fázisCsak meghívásos
An Extension Study to Assess Long-Term Safety of Eplontersen in Adults With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Where
Brno, Prague
Életkor
18 év and over
People
1400 worldwide
Run by
Ionis Pharmaceuticals, Inc.
See details and how to joinNCT05667493